Until in NYC: Engineering the Future of Reversible Cryopreservation

​Grab some food and join us for a conversation with leaders from Until, a venture-backed biotech startup that has raised $100M+ (incl. Series A led by Founders Fund with participation from Lux Capital and Field Group).

​Learn how the team is building technology that bridges biology, engineering, and physics to transform the future of transplant medicine and make reversible organ cryopreservation a reality.

​Join us on Tuesday, November 4 at 5:30pm at Memorial Sloan Kettering for an informal info session with:

• ​Hunter Davis, Cofounder & Chief Scientific Officer

• ​Arash Farhadi, Head of Molecular Development

• ​John Bailey, Head of Hardware

• ​Fynn Comerford, Chief of Staff & Director of Strategy

​As they share how their multidisciplinary teams are solving one of medicine’s most urgent challenges — ensuring every donated organ reaches a patient in time.

​Browse current openings here.

​(Optional to share your resume in advance with [email protected])